Clinical trial
Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk…
NCT00004414 · University of Michigan, Other · Completed
Key facts
| NCT number | NCT00004414 |
|---|---|
| Title | Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis |
| Lead sponsor | University of Michigan, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cholestasis |
| Intervention type | Drug |
| Interventions | sincalide |
| Enrollment | 252 |
| Start date | Sep 1, 1997 |
| Completion | Jun 1, 2002 |
| First posted | Oct 19, 1999 |
| Last update posted | Mar 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: